These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33927256)

  • 1. Inhibition of glypican-1 expression induces an activated fibroblast phenotype in a human bone marrow-derived stromal cell-line.
    Kaur SP; Verma A; Lee HK; Barnett LM; Somanath PR; Cummings BS
    Sci Rep; 2021 Apr; 11(1):9262. PubMed ID: 33927256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth.
    Quach ND; Kaur SP; Eggert MW; Ingram L; Ghosh D; Sheth S; Nagy T; Dawson MR; Arnold RD; Cummings BS
    Sci Rep; 2019 Aug; 9(1):11478. PubMed ID: 31391540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming of normal fibroblasts into ovarian cancer-associated fibroblasts via non-vesicular paracrine signaling induces an activated fibroblast phenotype.
    Axemaker H; Plesselova S; Calar K; Jorgensen M; Wollman J; de la Puente P
    Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119801. PubMed ID: 39038611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.
    Doldi V; Tortoreto M; Colecchia M; Maffezzini M; Percio S; Giammello F; Brandalise F; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2024 Jun; 43(1):161. PubMed ID: 38858661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Nox4-dependent ROS signaling attenuates prostate fibroblast activation and abrogates stromal-mediated protumorigenic interactions.
    Sampson N; Brunner E; Weber A; Puhr M; Schäfer G; Szyndralewiez C; Klocker H
    Int J Cancer; 2018 Jul; 143(2):383-395. PubMed ID: 29441570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.
    Comito G; Pons Segura C; Taddei ML; Lanciotti M; Serni S; Morandi A; Chiarugi P; Giannoni E
    Oncotarget; 2017 Jan; 8(1):118-132. PubMed ID: 27223431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silibinin prevents prostate cancer cell-mediated differentiation of naïve fibroblasts into cancer-associated fibroblast phenotype by targeting TGF β2.
    Ting HJ; Deep G; Jain AK; Cimic A; Sirintrapun J; Romero LM; Cramer SD; Agarwal C; Agarwal R
    Mol Carcinog; 2015 Sep; 54(9):730-41. PubMed ID: 24615813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment.
    Spaeth EL; Labaff AM; Toole BP; Klopp A; Andreeff M; Marini FC
    Cancer Res; 2013 Sep; 73(17):5347-59. PubMed ID: 23838935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid selection of mesenchymal stem and progenitor cells in primary prostate stromal cultures.
    Brennen WN; Kisteman LN; Isaacs JT
    Prostate; 2016 May; 76(6):552-64. PubMed ID: 26732992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells.
    Lund ME; Howard CB; Thurecht KJ; Campbell DH; Mahler SM; Walsh BJ
    BMC Cancer; 2020 Dec; 20(1):1214. PubMed ID: 33302918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins.
    Ojalill M; Virtanen N; Rappu P; Siljamäki E; Taimen P; Heino J
    Prostate; 2020 Jun; 80(9):715-726. PubMed ID: 32364250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
    Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
    Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.
    Hughes RM; Simons BW; Khan H; Miller R; Kugler V; Torquato S; Theodros D; Haffner MC; Lotan T; Huang J; Davicioni E; An SS; Riddle RC; Thorek DLJ; Garraway IP; Fertig EJ; Isaacs JT; Brennen WN; Park BH; Hurley PJ
    Cancer Res; 2019 Jul; 79(14):3636-3650. PubMed ID: 31123087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression.
    Pietrovito L; Iozzo M; Bacci M; Giannoni E; Chiarugi P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
    Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
    Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression.
    Shen T; Li Y; Zhu S; Yu J; Zhang B; Chen X; Zhang Z; Ma Y; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):36. PubMed ID: 32066485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
    Borriello L; Nakata R; Sheard MA; Fernandez GE; Sposto R; Malvar J; Blavier L; Shimada H; Asgharzadeh S; Seeger RC; DeClerck YA
    Cancer Res; 2017 Sep; 77(18):5142-5157. PubMed ID: 28687621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stem cells in microenvironment transform into cancer-associated fibroblasts to promote the progression of B-cell acute lymphoblastic leukemia.
    Pan C; Liu P; Ma D; Zhang S; Ni M; Fang Q; Wang J
    Biomed Pharmacother; 2020 Oct; 130():110610. PubMed ID: 34321159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.